Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies

Calcium oxalate (CaOx) crystal‐induced nephropathies comprise a range of kidney disorders, for which there are no efficient pharmacological treatments. Although CaOx crystallization inhibitors have been suggested as a therapeutic modality already decades ago, limited progress has been made in the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kletzmayr, Anna, Mulay, Shrikant R., Motrapu, Manga, Luo, Zhi, Anders, Hans‐Joachim, Ivarsson, Mattias E., Leroux, Jean‐Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175250/
https://www.ncbi.nlm.nih.gov/pubmed/32328427
http://dx.doi.org/10.1002/advs.201903337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175250/
https://www.ncbi.nlm.nih.gov/pubmed/32328427
http://dx.doi.org/10.1002/advs.201903337

Ejemplares similares